Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Receivables - Affiliates (2020 - 2022)

Abvc Biopharma (ABVC) has disclosed Receivables - Affiliates for 3 consecutive years, with $3.7 million as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Receivables - Affiliates rose 422.81% year-over-year to $3.7 million, compared with a TTM value of $3.7 million through Jun 2022, up 422.81%, and an annual FY2021 reading of $1.3 million, up 84.79% over the prior year.
  • Receivables - Affiliates was $3.7 million for Q2 2022 at Abvc Biopharma, up from $2.7 million in the prior quarter.
  • Across five years, Receivables - Affiliates topped out at $3.7 million in Q2 2022 and bottomed at $561085.0 in Q3 2021.
  • Average Receivables - Affiliates over 3 years is $1.5 million, with a median of $710257.0 recorded in 2021.
  • The sharpest move saw Receivables - Affiliates surged 84.79% in 2021, then skyrocketed 422.81% in 2022.
  • Year by year, Receivables - Affiliates stood at $696255.0 in 2020, then surged by 84.79% to $1.3 million in 2021, then soared by 188.61% to $3.7 million in 2022.
  • Business Quant data shows Receivables - Affiliates for ABVC at $3.7 million in Q2 2022, $2.7 million in Q1 2022, and $1.3 million in Q4 2021.